The Source for Patent Analysis, announced the release of its comprehensive Stem Cell Industry Report analyzing the U.S. Stem Cell patent landscape. Stem cells are particularly attractive for use as cellular therapies because they self-renew and have the capacity to produce many different specialized cell types. The Report evaluates 911 issued U.S. patents relating to stem cell technologies. The stem cell patents have been categorized by stem cell type or origin and by the therapeutic methods contemplated in the patent claims for treating diseases...
More...
More...